Maternal, fetal complications are correlated with hypertensive disorders during pregnancy. In this context, maternal blood uric acid level is reported to be one of the prognostic factors in determining the perinatal out come. The purpose of the present study is to estimate serum uric acid levels in preeclamptic, eclamptic and normotensive groups to identify woman who are at high risk of developing the disease early in pregnancy. The study may provide possible biochemical parameter in preeclampsia and eclamsia. This is because early identification of biochemical markers of the disease would not only facilitate to identify those at increased risk for pre eclampsia but also help to determine those patients likely to benefit from interventional measures. A total 50 patients were selected and categorized into three groups. 30 among 50 woman, were pregnancy induced hypertension BP>140/90 mm Hg. Who were as the experimental group and remaining 20 were normotensive (BP <140/90 mm Hg) taken as control (n=20). The experimental group was further categorized into two groups having 20 woman in preeclampsia (n=20), and Ten in eclampsia (n=10). The serum uric acid level studied in various study group showed a significant in pre eclampsia (n=20) and the eclamptic(n=10). The serum uric acid level for women with pre eclamsia 5 mg/dl-6.3 mg/dl n-10) were significant higher than those of controls (4-56 mg/dl n=20) more ever, it was experimentally found that the individual values of observed serum uric acid in preeclamptics and eclamptic were relatively higher than those of the average values of normotensive. In the setting of chronic hypertension, however a serum uric acid level at> or =5.5 mg/dl could identify women with increased likelihood of having superimposed pre eclampsia. A comparison between three groups related that hyperuricemia in patient with preeclampsia,eclampsia is certainly a risk factor for several perinal and maternal complications.
Introduction
Preeclampsia is a multisystem disorder of pregnancy charecterized by high blood pressure and large amount of protein in urine. Preeclampsia causes decreasing blood supply to organ due to vasospasm 2 . It contributes to both maternal and perinatal morbidity and mortality in both developed and developing countries 3 . It is well known that preeclampsia is one of the potential complication contributing to preterm labour, maternal mortality, Intrauterine growth retarded, intrauterine death and many such related complications. The clinical utility of serum uric acid as a marker of preeclampsia has been substantiated 4 . Maternal hypertensive, even in its severe form, without hyperuricemia is associated with a good prognosis for the foetus 5 . Perinatal mortality, however, is markedly increased when maternal plasma urate is raised. According to study carried out in Argentina, determination of serum uric acid as a screening tool for pregnancy complication is an easy expensive method without for prognostications of perinatal out come associated with severe preeclampsia 6 . Over the years, a lot of interest has been directed at the studies on the role of serum uric acid and in the pathogenesis of pregnancy induced hypertension, preeclampsia. A number of important studies are available which confusingly and often complicating describe the dependence of this parameter level in preeclampsia and normotensive groups. The serum uric acid levels were found to be significantly elevated in the preeclamsia with references to the normotensive in a number of studies 7 . The results of some studies in normotensive pregnant women suggest that serum uric acid levels begin to rise before the appearance of hypertension and proteinuria 8 . It is important therefore, to identify woman who at high risk of developing the disease in early pregnancy. This study therefore involves estimation of serum uric acid level in preeclampsia, Eclampsia and normotensive groups. The objective of this study was to determine serum uric acid can be used as a prognostic factor for determining the outcome of preeclampsia and eclampsia.
Material and Methods
This study was conducted in the department of obstetrics and gynaecological department, Rajshahi Medical College. The cases for the present study were selected from the antenatal out patient department according to specific criteria like women with age group between 18-30 years, primi gravidae with known last menstrual period and gestational age between 20-40 weeks. If menstrual history and examination findings were not correlating, early ultrasonography report was seen to find out exact period of gestation. Exclusion criteria were known hypertension, diabetes mellitus, multiple pregnancy, hyperuricemia, or renal dysfunction and liver dysfunction. A total of 50 subjects were selected in this study. All the 50 patients included in the present study were subjected to a detailed history taken, systemic examination and routine antenatal investigations. 30 among 50 women were pregnancy induced hypertension (BP> 140/90 mm Hg and proteinurea > 0.3 grm l/day and remaining 20 were normotension BP < 140/ 90 mm Hg and non-Proteinuric as control (n=20). The experimental group was further categorized into two groups, having 20 women in preeclampsia (Group II n=20 and I ten in eclampsia) ( Group III n=10)
Results:
The serum uric acid level in various study group are presented in Table I 
In Table I shows serum uric acid level studied in various study group showed a significant increase in group II (Preeclampsia n=20) and group III (Eclampsia n=10). Moreover, it was also experimentally found that the individual values of serum uric acid in Preeclampsia were relatively higher than those of the average values of normotensives. Table IV shows in control group there is no such complication only caesarean section rate in group I (16%) In group II Preeclampsia group maternal mortality 2 (4%) caesarean section 10 (20%) and eclampsia 5 (10%). In group III eclampsia maternal mortality 6(8%), Caesarean section 5 (10%).
Discussion:
Preeclampsia and eclampsia are the two major categories of toxemias of pregnancy. The study may provide possible biochemical parameters in toxemias of pregnancy. Preeclampsia is responsible for approximately 20% of hypertension cases during gestation. Etiology of pre-Eclampsia and eclampsia includes abnormal trophoblast invasion, coagulation abnormalities, vascular endothelial damage, cardiovascular mal adaptation, immunological phenomena, genetic predisposition and dietary deficiency or excesses. Increased uric acid level in pre eclampsia and eclampsia are also due to increased purine catabolism. Serum uric acid levels were seen to be increased significantly both pre eclampsia and eclampsia. Hyperuricemia is associated with the severity of the preeclampsia and foetal out come. Increased uric acid concentration precedes the signs and symptom of the disease frequently antedates any change in glomerular filtration rate. A correlation between high serum uric acid and severity of disease and perinatal mortality has been suggested earlier. It has been proposed that increased production of uric acid and occurs in addition to altered renal handling 9 . Therefore, high serum uric acid levels actas both marker of preeclampsia and also a protective agent against free radiacals preeclampsia leads to altered renal excretion of uric acid leading to increased level of serum uric acid 10 . According to a study in women with preeclampsia who developed convulsion, there in variably was a further rise in the plasma uric acid level 11 . Monitoring the serum uric acid levels, we were able to identify a serum uric acid value that could be used to differentiate hypertensive disease. Hence monitoring of plasma uric acid level in those with pre eclampsia will help to predict those women that will develop eclampsia. Elevated serum uric acid level have also been interpreted to act as an important cofactor involved in the pathogenesis and manifestation of pre eclampsia disorder 12 . It has been proposed recently that increased oxidative stress and formation of reactive oxygen species, as another contributing source of hyperuricemia noted in pre eclampsia 13 . Uric acid possessing water soluble or hydrophilic antioxidant characteristics, may delay or inhibit cellar damage mainly through the free radical scavenging property, it also presents strong antioxidant activity towards reactive oxygen species in aqueous phase 14 . Uric acid thus may function as a marker of oxidative stress tissue injury dysfunction.
Elevated serum uric acid concentrations predict the development of hypertension. A review inferred that uric acid and its level generally increases once the disease manifests and plasma levels of uric acid may often correlate with disease severity 15 . Compared to other bio marker of preeclampsia. Under study such FL T-1, PIGF (Placental growth factor), SENG (Soluble endoglin), uric acid is much cheaper, widely available and has much better sensitivity and specificity.
